Hikma and GSK end talks on Egypt and Tunisia

15 March 2021 - Deborah Wilkes

Premium

Hikma Pharmaceuticals and GlaxoSmithKline (GSK) have ended their discussions about a transaction in Egypt and Tunisia.

Click tags below for more information on topics:

GlaxoSmithKline Hikma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: